68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases

被引:30
作者
Einspieler, Ingo [1 ]
Tauber, Robert [2 ]
Maurer, Tobias [2 ]
Schwaiger, Markus [1 ]
Eiber, Matthias [1 ]
机构
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Ismaningerstr 22, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, D-81675 Munich, Germany
关键词
Ga-68-PSMA; PET/CT; prostate cancer; renal cell cancer; PSMA EXPRESSION; PET/CT;
D O I
10.1097/RLU.0000000000001128
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Ga-68 prostate-specific membrane antigen (PSMA)-HBED-CC PET/CT in a patient with a history of both prostate cancer (PC) and renal cell cancer (RCC) shows high PSMA expression in the residual right seminal vesicle suggestive of local recurrence of PC as well as suspected PSMA-positive mediastinal, retroperitoneal, and iliac lymph nodes. Regarding the latter, biopsy revealed lymph node metastases from RCC excluding PC metastases. This case exemplarily demonstrates that high PSMA expression in RCC metastases can potentially mimic PC metastases. Thus, for accurate interpretation of imaging results in PC patients with additional primary tumors, knowledge of PSMA expression of non-PC tissue is necessary.
引用
收藏
页码:E261 / E262
页数:2
相关论文
共 9 条
[1]   The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Avtzi, Eleni ;
Giesel, Frederik L. ;
Holland-Letz, Tim ;
Linhart, Heinz G. ;
Eder, Matthias ;
Eisenhut, Michael ;
Boxler, Silvan ;
Hadaschik, Boris A. ;
Kratochwil, Clemens ;
Weichert, Wilko ;
Kopka, Klaus ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :197-209
[2]   Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study [J].
Ahmadzadehfar, Hojjat ;
Rahbar, Kambiz ;
Kuerpig, Stefan ;
Boegemann, Martin ;
Claesener, Michael ;
Eppard, Elisabeth ;
Gaertner, Florian ;
Rogenhofer, Sebastian ;
Schaefers, Michael ;
Essler, Markus .
EJNMMI RESEARCH, 2015, 5 :1-8
[3]  
Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO
[4]  
2-S
[5]  
Chang SS, 1999, CANCER RES, V59, P3192
[6]   68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma [J].
Demirci, Emre ;
Ocak, Meltem ;
Kabasakal, Levent ;
Decristoforo, Clemens ;
Talat, Zubeyir ;
Halac, Metin ;
Kanmaz, Bedii .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) :1461-1462
[7]   Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy [J].
Eiber, Matthias ;
Maurer, Tobias ;
Souvatzoglou, Michael ;
Beer, Ambros J. ;
Ruffani, Alexander ;
Haller, Bernhard ;
Graner, Frank-Philipp ;
Kuebler, Hubert ;
Haberhorn, Uwe ;
Eisenhut, Michael ;
Wester, Hans-Juergen ;
Gschwend, Juergen E. ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) :668-674
[8]   [177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer [J].
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Eder, Matthias ;
Afshar-Oromieh, Ali ;
Benesova, Martina ;
Mier, Walter ;
Kopka, Klaus ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (06) :987-988
[9]   First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT [J].
Verburg, Frederik A. ;
Krohn, Thomas ;
Heinzel, Alexander ;
Mottaghy, Felix M. ;
Behrendt, Florian F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (10) :1622-1623